Experienced in CACH Syndrome

Dr. Sachin K. Agarwal

Neurology
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
Experienced in CACH Syndrome
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sachin Agarwal is a Neurologist in New York, New York. Dr. Agarwal is rated as an Experienced provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Subarachnoid Hemorrhage, Apoplexy, Stroke, Osteotomy, and Thrombectomy.

His clinical research consists of co-authoring 207 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of CACH Syndrome.

Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032
Other Locations
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
51 W 51st St, Fl 3 Suite 360, New York, NY 10019

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer
Enrollment Status: Terminated
Publish Date: July 16, 2025
Intervention Type: Radiation
Study Phase: Phase 2
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Active_not_recruiting
Publish Date: May 09, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Pilot Study of Stellate Ganglion Blockade + Psychoeducation to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors
A Pilot Study of Stellate Ganglion Blockade + Psychoeducation to Reduce Cardiac Anxiety and PTSD Symptoms in Cardiac Arrest Survivors
Enrollment Status: Terminated
Publish Date: July 31, 2024
Intervention Type: Procedure, Behavioral
Study Phase: Not Applicable
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: March 20, 2023
Intervention Type: Drug
Study Drugs: CB-839, Cabozantinib
Study Phase: Phase 2
Written Exposure Therapy to Prevent PTSD in Survivors of Acute Cardiovascular Events: A Pilot Randomized Clinical Trial
Written Exposure Therapy to Prevent PTSD in Survivors of Acute Cardiovascular Events: A Pilot Randomized Clinical Trial
Enrollment Status: Terminated
Publish Date: September 16, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
View 6 Less Clinical Trials

207 Total Publications

The Missing Measure: A Call to Standardize the Neurocognitive Assessments in Out-of-Hospital Cardiac Arrest Survivors.
The Missing Measure: A Call to Standardize the Neurocognitive Assessments in Out-of-Hospital Cardiac Arrest Survivors.
Journal: Resuscitation
Published: October 01, 2025
Similar Doctors
Distinguished in CACH Syndrome
Dr. Ilya Kister
Neurology
Distinguished in CACH Syndrome
Dr. Ilya Kister
Neurology

New York University

530 1st Ave, 
New York, NY 
 (7.1 miles away)
212-263-7300
Languages Spoken:
English
See accepted insurances

Ilya Kister is a Neurologist in New York, New York. Dr. Kister is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Multiple Sclerosis (MS), Neuromyelitis Optica, Optic Neuritis, Hip Replacement, and Knee Replacement.

Distinguished in CACH Syndrome
Dr. Babak B. Navi
Neurology
Distinguished in CACH Syndrome
Dr. Babak B. Navi
Neurology

Weill Medical College Of Cornell

525 E 68th St, 
New York, NY 
 (5.3 miles away)
212-746-2323
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Babak Navi is a Neurologist in New York, New York. Dr. Navi is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Increased Intracranial Pressure, Thrombectomy, and Gastrostomy.

Distinguished in CACH Syndrome
Dr. Avtar K. Singh
Neurology
Distinguished in CACH Syndrome
Dr. Avtar K. Singh
Neurology
259 Heathcote Rd, 
Scarsdale, NY 
 (13.2 miles away)
914-723-8100
Languages Spoken:
English
See accepted insurances

Avtar Singh is a Neurologist in Scarsdale, New York. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are CACH Syndrome, Seizures, Memory Loss, and Epilepsy in Children.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Agarwal's expertise for a condition
ConditionClose
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile